Skip to content
Clinical Trials – home

Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD

Research site

Bulgaria Ulitsa Stara Planina 54, 2900 Gotse Delchev, Bulgaria

  • 5 trials recruiting
  • Cardiac failure · Acute myocardial infarction · Embolism venous
  • Adult patients

About Specializations

Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD in Gotse Delchev, Bulgaria specialises in clinical trials of conditions such as Cardiac failure, Acute myocardial infarction, Embolism venous, Heart failure with reduced ejection fraction, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Disease Clinical Research

The Clinic of Cardiology at Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD focuses on innovative studies aimed at improving outcomes for patients with heart failure and related conditions.

  • Evaluation of a novel therapy (JTT-861) for heart failure with reduced ejection fraction
  • Combination of vicadrostat and empagliflozin to reduce cardiovascular death and hospitalisation
  • Investigation of NNC0487-0111 in HFpEF and obesity

These trials aim to test new treatments, assess safety, and measure impacts on hospitalization and mortality, offering hope for better management of chronic cardiac conditions.

Acute Myocardial Infarction Studies

Research at the site includes studies targeting the early treatment of acute myocardial infarction (AMI) to lower the risk of future cardiovascular events.

  • Self‑administered selatogrel for rapid symptom relief in suspected AMI
  • Monthly ziltivekimab injections to reduce inflammation and major adverse cardiovascular events after AMI
  • Exploration of inflammatory pathways (IL‑6) as a therapeutic target in post‑AMI patients

The primary goal is to demonstrate efficacy and safety of these approaches, potentially shaping new standards for post‑heart‑attack care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Stara Planina 542900 Gotse DelchevBulgaria
Recruiting now
5 trials
Conditions studied
5

More sites in Gotse DelchevBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

8 clinical trials

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Embolism venous

Not recruiting

Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:JTT-861 monohydrochloride dihydrate
  • Sponsor:Akros Pharma Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.